Gujarat Themis Biosyn Limited (BOM:506879)
India
· Delayed Price · Currency is INR 296.75
-4.20 (-1.40%)
At close: Mar 6, 2026
Gujarat Themis Biosyn Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 1,593 | 1,508 | 1,698 | 1,484 | 1,149 | 905.63 | Upgrade
|
| Revenue Growth (YoY) | 2.74% | -11.20% | 14.45% | 29.20% | 26.82% | 6.39% | Upgrade
|
| Cost of Revenue | 600.09 | 593.2 | 687.4 | 573.39 | 181.25 | 168.27 | Upgrade
|
| Gross Profit | 993.18 | 914.8 | 1,011 | 910.46 | 967.29 | 737.36 | Upgrade
|
| Selling, General & Admin | 170.5 | 137.35 | 128.68 | 89.42 | 71.99 | 74.2 | Upgrade
|
| Other Operating Expenses | 91.95 | 80.38 | 95.04 | 76.04 | 307.64 | 249.14 | Upgrade
|
| Operating Expenses | 363.54 | 271.47 | 259.08 | 191.22 | 401.96 | 340.66 | Upgrade
|
| Operating Income | 629.64 | 643.33 | 751.75 | 719.25 | 565.33 | 396.7 | Upgrade
|
| Interest Expense | -9.83 | -2.33 | -1.43 | -0.95 | -6.56 | -5.25 | Upgrade
|
| Interest & Investment Income | 7.12 | 7.12 | 40.35 | 51.29 | 32.61 | 21.51 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.53 | 0.53 | 0.23 | - | 0.09 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 10.95 | 6.73 | 2.45 | 5.06 | -1.13 | -4.26 | Upgrade
|
| EBT Excluding Unusual Items | 638.41 | 655.38 | 793.34 | 774.65 | 590.35 | 408.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 0.12 | Upgrade
|
| Pretax Income | 638.41 | 655.38 | 793.34 | 774.65 | 590.35 | 408.82 | Upgrade
|
| Income Tax Expense | 160.52 | 167.66 | 201.71 | 194.96 | 154.1 | 107.02 | Upgrade
|
| Net Income | 477.89 | 487.72 | 591.63 | 579.69 | 436.24 | 301.8 | Upgrade
|
| Net Income to Common | 477.89 | 487.72 | 591.63 | 579.69 | 436.24 | 301.8 | Upgrade
|
| Net Income Growth | -9.25% | -17.56% | 2.06% | 32.88% | 44.55% | 27.48% | Upgrade
|
| Shares Outstanding (Basic) | 109 | 109 | 109 | 109 | 109 | 109 | Upgrade
|
| Shares Outstanding (Diluted) | 109 | 109 | 109 | 109 | 109 | 109 | Upgrade
|
| EPS (Basic) | 4.39 | 4.48 | 5.43 | 5.32 | 4.00 | 2.77 | Upgrade
|
| EPS (Diluted) | 4.39 | 4.48 | 5.43 | 5.32 | 4.00 | 2.77 | Upgrade
|
| EPS Growth | -9.13% | -17.56% | 2.06% | 32.88% | 44.57% | 27.46% | Upgrade
|
| Free Cash Flow | - | -251.22 | -104.32 | 157.74 | 264.16 | 74.73 | Upgrade
|
| Free Cash Flow Per Share | - | -2.31 | -0.96 | 1.45 | 2.42 | 0.69 | Upgrade
|
| Dividend Per Share | - | 0.670 | 1.000 | 0.720 | 0.800 | - | Upgrade
|
| Dividend Growth | - | -33.00% | 38.89% | -10.00% | - | - | Upgrade
|
| Gross Margin | 62.34% | 60.66% | 59.52% | 61.36% | 84.22% | 81.42% | Upgrade
|
| Operating Margin | 39.52% | 42.66% | 44.27% | 48.47% | 49.22% | 43.80% | Upgrade
|
| Profit Margin | 29.99% | 32.34% | 34.84% | 39.07% | 37.98% | 33.32% | Upgrade
|
| Free Cash Flow Margin | - | -16.66% | -6.14% | 10.63% | 23.00% | 8.25% | Upgrade
|
| EBITDA | 684.01 | 684.61 | 775.58 | 737.48 | 580.14 | 414.03 | Upgrade
|
| EBITDA Margin | 42.93% | 45.40% | 45.67% | 49.70% | 50.51% | 45.72% | Upgrade
|
| D&A For EBITDA | 54.37 | 41.28 | 23.83 | 18.24 | 14.81 | 17.33 | Upgrade
|
| EBIT | 629.64 | 643.33 | 751.75 | 719.25 | 565.33 | 396.7 | Upgrade
|
| EBIT Margin | 39.52% | 42.66% | 44.27% | 48.47% | 49.22% | 43.80% | Upgrade
|
| Effective Tax Rate | 25.14% | 25.58% | 25.42% | 25.17% | 26.10% | 26.18% | Upgrade
|
| Revenue as Reported | 1,622 | 1,532 | 1,742 | 1,550 | 1,189 | 938.29 | Upgrade
|
| Advertising Expenses | - | 0.07 | 0.16 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.